| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/11/2012 | CN101534791B Compositions containing quaternary ammonium compounds |
| 01/11/2012 | CN101530519B Electrothermal plaster for treating mastitis or mastosis |
| 01/11/2012 | CN101491628B Lycium-rehmannia preparation preparation method |
| 01/11/2012 | CN101491568B Medicine combination capable of resisting fatigue and radiation hazard and preparation method thereof |
| 01/11/2012 | CN101485643B Plant hollow capsule |
| 01/11/2012 | CN101468144B Chinese medicine compound preparation for treating ventricular premature beat |
| 01/11/2012 | CN101417072B Effervescence tablet for treating gynecologic disease |
| 01/11/2012 | CN101400343B Modified release formulations containing drug-ion exchange resin complexes |
| 01/11/2012 | CN101396542B Traditional Chinese medicine formulation for treating gastrosis and preparation method thereof |
| 01/11/2012 | CN101301434B Chinese medicinal composition for treating cervical vertebra disease |
| 01/11/2012 | CN101293053B Detection method for E-jiao hematinic ointment |
| 01/11/2012 | CN101229366B Applications of fibroblast growth factor on preparing vasculogenesis-promoting medicine |
| 01/11/2012 | CN101181605B Capsule for curing medical postoperative colporrhagia as well as preparation method, identification method and content determination method |
| 01/11/2012 | CN101175411B Delivery systems for active composition of edible composition including packaging material and active components |
| 01/11/2012 | CN101138549B Mitiglinide calcium self-microemulsifying drug delivery system |
| 01/11/2012 | CN101108250B Mono- and disaccharide derivatives |
| 01/11/2012 | CN101053593B Shenghong heat-clearing granule and its preparation method |
| 01/11/2012 | CN101049123B Method for preparing tea of natural pine needle powder |
| 01/11/2012 | CN101045083B Dizziness-clearing soft capsule, its preparing method and detection method |
| 01/11/2012 | CN101040955B Medical cream for treating diseases of bones and joints and its preparing process |
| 01/11/2012 | CN101031283B Pharmaceutical compositions for drug delivery |
| 01/11/2012 | CN101027044B Oral dosage form safeguarded against abuse |
| 01/11/2012 | CN101022787B Oral dosage form safeguarded against abuse containing (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol |
| 01/11/2012 | CN101005828B Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents |
| 01/10/2012 | US8093230 Supersaturated aqueous ifosfamide compositions |
| 01/10/2012 | US8093228 Bisphosphonate formulation |
| 01/10/2012 | US8093219 Topical application of ivermectin for the treatment of dermatological conditions/afflictions |
| 01/10/2012 | US8093038 Apparatus and method for encapsulating pancreatic cells |
| 01/10/2012 | US8092836 Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
| 01/10/2012 | US8092835 Injectable microspheres |
| 01/10/2012 | US8092834 Zinc oxide-covering silica, -talc and/or -mica; complex powder comprising enzyme adsorption and operation sites |
| 01/10/2012 | US8092833 Compositions containing inclusion complexes |
| 01/10/2012 | US8092832 Generally linear effervescent oral fentanyl dosage form and methods of administering |
| 01/10/2012 | US8092831 A safe and effective twelve to twenty-four hour formulation comprising a decongestant core which has a delay release coating and an immediate release coating of both drugs, a water soluble binder and surfactant; one-a-day orally |
| 01/10/2012 | US8092830 Lactic acid polymer and process for producing the same |
| 01/10/2012 | US8092829 Use of R-arylpropionic acids for treating illnesses with a rheumatic nature |
| 01/10/2012 | US8092828 Administering mixture of cytarabine and anthracycline |
| 01/10/2012 | US8092827 Medical non-crosslinked pressure-sensitive adhesive composition, medical adhesive sheet employing the same, and process for producing medical non-crosslinked pressure-sensitive adhesive composition |
| 01/10/2012 | US8092825 Glycan binding proteins as therapeutic targets for retinal disorders and treatment methods based thereon |
| 01/10/2012 | US8092820 Dry hemostatic compositions and methods for their preparation |
| 01/10/2012 | US8092818 Medical devices having bioactive surfaces |
| 01/10/2012 | US8092815 Produced by dissolving chitosan in acidic solution, adding silver nitrate, basification with ammonium hydroxide, filtering, washing, drying and grinding; finishing solution for textiles or polymeric articles; microfiltration and ultrafiltration membranes |
| 01/10/2012 | US8092795 Liquid seasoning |
| 01/10/2012 | US8092785 Process for milling poorly soluble drugs in presence of liquid propellants |
| 01/10/2012 | US8092779 Post-biopsy cavity treatment implants and methods |
| 01/10/2012 | US8091801 Generation of therapeutic microfoam |
| 01/10/2012 | CA2633027C Adhesive pharmaceutical preparation |
| 01/10/2012 | CA2619474C Metronidazole-based dermatological foam and emulsions for the production thereof |
| 01/10/2012 | CA2581002C Less abusable pharmaceutical preparations |
| 01/10/2012 | CA2571202C Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine |
| 01/10/2012 | CA2564742C Quaternary quinuclidine derivatives and their use as muscarinic receptor antagonists |
| 01/10/2012 | CA2530117C Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix |
| 01/10/2012 | CA2525542C Oral sustained release pharmaceutical composition of beraprost sodium |
| 01/10/2012 | CA2522308C Radioactively marked microparticles, method for the production thereof and use of the same |
| 01/10/2012 | CA2513751C Sustained release device and method for ocular delivery of adrenergic agents |
| 01/10/2012 | CA2503719C Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 01/10/2012 | CA2498152C Treatment of cns disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
| 01/10/2012 | CA2486553C Ibuprofen suspension |
| 01/10/2012 | CA2458821C Use of non-toxic crosslinking agents to inhibit mechanical degradation of collagenous tissues |
| 01/10/2012 | CA2444702C Articles for therapeutic paraffin treatment and methods of use |
| 01/10/2012 | CA2440605C Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 01/10/2012 | CA2428144C Compositions of interferon-beta stabilized with highly purified mannitol |
| 01/10/2012 | CA2354029C Gene therapy for cardiomyopathy |
| 01/10/2012 | CA2348540C Transdermal delivery of medications using a combination of penetration enhancers |
| 01/10/2012 | CA2348167C Pharmaceutical administration form for peptides, process for its preparation, and use |
| 01/10/2012 | CA2334483C Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 01/10/2012 | CA2267650C Non-naturally occurring lipoprotein particle |
| 01/10/2012 | CA2222328C Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| 01/10/2012 | CA2124259C Galenical formulations |
| 01/08/2012 | CA2745289A1 Films for delivery of a therapeutic agent |
| 01/05/2012 | WO2012003466A1 Single-walled carbon nanotube/sirna complexes and methods related thereto |
| 01/05/2012 | WO2012003460A2 Compositions and methods for bacterial lysis and neutral lipid production |
| 01/05/2012 | WO2012003441A1 Self-emulsifying oil |
| 01/05/2012 | WO2012003370A2 Functional vascularization with biocompatible polysaccharide-based hydrogels |
| 01/05/2012 | WO2012003365A1 Filaments comprising an ingestible active agent nonwoven webs and methods for making same |
| 01/05/2012 | WO2012003361A2 Nanoemulsion vaccines |
| 01/05/2012 | WO2012003350A1 Methods of delivering a health care active by administering personal health care articles comprising a filament |
| 01/05/2012 | WO2012003349A2 Dissolvable fibrous web structure article comprising active agents |
| 01/05/2012 | WO2012003290A2 Dental composites comprising nanoparticles of amorphous calcium phosphate |
| 01/05/2012 | WO2012003231A1 Sustained release composition comprising an amine as active agent and a salt of a cyclic organic acid |
| 01/05/2012 | WO2012003210A1 Implant processing methods for thermally labile and other bioactive agents and implants prepared from same |
| 01/05/2012 | WO2012003181A2 Solid forms |
| 01/05/2012 | WO2012003141A1 Compounds for the treatment of posterior segment disorders and diseases |
| 01/05/2012 | WO2012002986A2 Decellularized and delipidized extracellular matrix and methods of use |
| 01/05/2012 | WO2012002921A1 Multiple dosage forms comprising fenofibrate or fenofibric acid in combination with hmg co a reductase inhibitors such as statins |
| 01/05/2012 | WO2012002920A1 New dosage forms for treatment of cardiovascular diseases |
| 01/05/2012 | WO2012002918A1 Formulation for osteoporosis |
| 01/05/2012 | WO2012002891A1 Coated effervescent tablet |
| 01/05/2012 | WO2012002760A2 Method for treating and diagnosing cancer by using cell-derived microvesicles |
| 01/05/2012 | WO2012002759A2 Microvesicles derived from cell protoplast, and use thereof |
| 01/05/2012 | WO2012002644A2 Sustained-release pharmaceutical composition containing pramipexole or pharmaceutically acceptable salt thereof with improved stability |
| 01/05/2012 | WO2012002640A2 Transdermal drug delivery system containing donepezil |
| 01/05/2012 | WO2012002547A1 Bosentan solid dispersion |
| 01/05/2012 | WO2012002464A1 ω3 FATTY ACID COMPOUND PREPARATION |
| 01/05/2012 | WO2012002391A1 Nanofibre laminate sheet |
| 01/05/2012 | WO2012002388A1 Drug delivery agent to sentinel lymph node |
| 01/05/2012 | WO2012002253A1 Composite particles which contain both cellulose and inorganic compound |
| 01/05/2012 | WO2012001977A1 Disintegrating composition and easily disintegrating compression molded article |
| 01/05/2012 | WO2012001705A2 Pharmaceutical compositions of (r)-lansoprazole |
| 01/05/2012 | WO2012001679A1 Injectable pharmaceutical compositions for the treatment of joints |